Advertisement

Topics

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

16:00 EDT 17 Aug 2017 | Medical Xpress

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Original Article: Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

NEXT ARTICLE

More From BioPortfolio on "Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...